FERINJEX-FCM

COMPOSITION : Ferric Carboxymaltose 50 mg/mL

Category:
Description

Product Description

FERINJEX FCM Injection contains Ferric Carboxymaltose 50 mg/mL, an intravenous iron preparation used for iron replacement when parenteral iron therapy is indicated.

Each 10 mL vial contains a total of 500 mg Ferric Carboxymaltose. The product is labeled for I.V. injection/infusion and is supplied as a single-dose vial.

Therapeutic Uses

Ferric carboxymaltose is used for iron replacement in patients with iron deficiency/iron deficiency anemia when intravenous iron therapy is appropriate.

Depending on the clinical situation, intravenous iron may be considered when:

  • Iron deficiency requires parenteral replacement
  • Oral iron is unsuitable or insufficient
  • More rapid iron replenishment is clinically required
  • The patient requires iron replacement under medical supervision

NOTE :The exact indication and administration should be determined by the treating healthcare professional.